Advertisement

Trials of Decision Aids for Prostate Cancer Screening

A Systematic Review

      Background

      Patient decision aids are used to promote informed decision making. This review examines the methods and findings of studies that have evaluated the impact of prostate cancer screening decision aids on patient outcomes.

      Methods

      MEDLINE, the Cochrane Registry, reference lists, and abstracts from professional meetings were searched through December 2006. Search terms included prostate cancer screening and decision making. Studies were included if a patient education intervention for prostate cancer screening had been evaluated against a control condition.

      Results

      Eighteen eligible trials, involving 6221 participants, were identified. Sixteen studies enrolled primary care patients, while the remaining two studies were community-based. All the prostate cancer screening decision aids were in English, with varied reading levels. Consistent with previous reviews, the patient decision aids improved patient knowledge and made patients more confident about their decisions. The aids appeared to decrease interest in prostate-specific antigen testing and screening behavior among patients seeking routine care (relative risk [RR]=0.88, 95% confidence interval [CI]=0.81–0.97, p=0.008); the aids had no impact on the screening behavior of patients seeking screening services. Additionally, patients who received patient decision aids were more likely to prefer watchful waiting as a treatment option if they were found to have prostate cancer than were controls (RR=1.53, 95% CI=1.31–1.77, p<0.001).

      Conclusions

      Prostate cancer screening decision aids enhance patient knowledge, decrease decisional conflict, and promote greater involvement in decision making. The absence of outcome measures that reflect all elements of informed decision making continues to limit the field.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. American Cancer Society. Cancer Facts and Figures 2002. Atlanta, Georgia 2002 Available online at: www.cancer.org.

        • Harris R.
        • Lohr K.N.
        Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.
        Ann Intern Med. 2002; 137: 917-929
        • American Urological Association (AUA)
        Prostate-specific antigen (PSA) best practice policy.
        Oncology (Williston Park). 2000; 14 (277–8, 280 passim): 267-272
      2. Screening for prostate cancer: recommendation and rationale.
        Ann Intern Med. 2002; 137: 915-916
        • American Academy of Family Physicians
        Summary of policy recommendations for periodic health examinations, revision 5.4.
        American Academy of Family Physicians, Leawood KS2003
        • Briss P.
        • Rimer B.
        • Reilley B.
        • et al.
        Promoting informed decisions about cancer screening in communities and healthcare systems.
        Am J Prev Med. 2004; 26: 67-80
        • Ferrini R.
        • Woolf S.H.
        • American College of Preventive Medicine practice policy
        Screening for prostate cancer in American men.
        Am J Prev Med. 1998; 15: 81-84
        • Smith R.A.
        • Cokkinides V.
        • Eyre H.J.
        American Cancer Society guidelines for the early detection of cancer, 2005.
        CA Cancer J Clin. 2005; 55: 31-44
        • Barry M.J.
        Health decision aids to facilitate shared decision making in office practice.
        Ann Intern Med. 2002; 136: 127-135
        • O’Connor A.M.
        • Stacey D.
        • Rovner D.
        • et al.
        Decision aids for people facing health treatment or screening decisions.
        Cochrane Database Syst Rev. 2003; 3 (CD001431)
        • Trevena L.
        • Barratt A.
        Integrated decision making: definitions for a new discipline.
        Patient Educ Couns. 2003; 50: 265-268
        • Evans R.
        • Edwards A.
        • Brett J.
        • et al.
        Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations.
        Patient Educ Couns. 2005; 58: 13-26
        • Whelan T.M.
        • O’Brien M.A.
        • Villasis-Keever M.
        • et al.
        Impact of cancer-related decision aids. evidence report/technology assessment Number 46.
        (AHRQ Publication No. 02-E004) Agency for Healthcare Research and Quality, Rockville MD2002 (July)
        • Zaza S.
        • Carande-Kulis V.G.
        • Sleet D.A.
        • et al.
        Methods for conducting systematic reviews of the evidence of effectiveness and economic efficiency of interventions to reduce injuries to motor vehicle occupants.
        Am J Prev Med. 2001; 21: 23-30
        • Frosch D.L.
        • Kaplan R.M.
        • Felitti V.
        The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test.
        J Gen Intern Med. 2001; 16: 391-398
        • Partin M.R.
        • Nelson D.
        • Radosevich D.
        • et al.
        Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors.
        J Gen Intern Med. 2004; 19: 835-842
        • Frosch D.L.
        • Kaplan R.M.
        • Felitti V.J.
        A randomized controlled trial comparing Internet and video to facilitate patient education for men considering the prostate specific antigen test.
        J Gen Intern Med. 2003; 18: 781-787
        • Taylor K.L.
        • Davis 3rd, J.L.
        • Turner R.O.
        • et al.
        Educating African American men about the prostate cancer screening dilemma: a randomized intervention.
        Cancer Epidemiol Biomarkers Prev. 2006; 15: 2179-2188
        • Sheridan S.L.
        • Felix K.
        • Pignone M.P.
        • Lewis C.L.
        Information needs of men regarding prostate cancer screening and the effect of a brief decision aid.
        Patient Educ Couns. 2004; 54: 345-351
        • Schapira M.M.
        • Meade C.
        • Nattinger A.B.
        Enhanced decision-making: the use of a videotape decision-aid for patients with prostate cancer.
        Patient Educ Couns. 1997; 30: 119-127
        • Hammond C.S.
        • Wasson J.H.
        • Walker-Corkery E.
        • Fowler F.J.
        • Barry M.J.
        A frequently used patient and physician-directed educational intervention does nothing to improve primary care of prostate conditions.
        Urology. 2001; 58: 875-881
        • Flood A.B.
        • Wennberg J.E.
        • Nease Jr., R.F.
        • Fowler Jr., F.J.
        • Ding J.
        • Hynes L.M.
        The importance of patient preference in the decision to screen for prostate cancer.
        J Gen Intern Med. 1996; 11: 342-349
        • Volk R.J.
        • Cass A.R.
        • Spann S.J.
        A randomized controlled trial of shared decision making for prostate cancer screening.
        Arch Fam Med. 1999; 8: 333-340
        • Volk R.J.
        • Spann S.J.
        • Cass A.R.
        • Hawley S.T.
        Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up.
        Ann Fam Med. 2003; 1: 22-28
        • Gattellari M.
        • Ward J.E.
        Does evidence-based information about screening for prostate cancer enhance consumer decision-making?.
        J Med Screen. 2003; 10: 27-39
        • Myers R.E.
        • Daskalakis C.
        • Cocroft J.
        • et al.
        Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening.
        J Natl Med Assoc. 2005; 97: 1143-1154
        • Watson E.
        • Hewitson P.
        • Brett J.
        • et al.
        Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men’s knowledge, attitudes and intention to be tested.
        Patient Educ Couns. 2006; 63: 367-379
        • Wilkins E.G.
        • Lowery J.C.
        • Hamill J.B.
        The impact of shared decision-making in prostate specific antigen (PSA) screening.
        Med Decis Making. 1996; 19: 525
        • Wolf A.M.
        • Nasser J.F.
        • Schorling J.B.
        The impact of informed consent on patient interest in prostate-specific antigen screening.
        Arch Intern Med. 1996; 156: 1333-1336
        • Gattellari M.
        • Ward J.E.
        A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening.
        Patient Educ Couns. 2005; 57: 168-182
        • Myers R.E.
        • Chodak G.W.
        • Wolf T.A.
        • et al.
        Adherence by African American men to prostate cancer education and early detection.
        Cancer. 1999; 86: 88-104
        • Ruthman J.L.
        • Ferrans C.E.
        Efficacy of a video for teaching patients about prostate cancer screening and treatment.
        Am J Health Promot. 2004; 18: 292-295
        • Schapira M.M.
        • VanRuiswyk J.
        The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests.
        J Fam Pract. 2000; 49: 418-424
        • Davison B.J.
        • Kirk P.
        • Degner L.F.
        • Hassard T.H.
        Information and patient participation in screening for prostate cancer.
        Patient Educ Couns. 1999; 37: 255-263
        • Wilt T.J.
        • Paul J.
        • Murdoch M.
        • Nelson D.
        • Nugent S.
        • Rubins H.B.
        Educating men about prostate cancer screening.
        Eff Clin Pract. 2001; 4: 112-120
      3. Foundation for Informed Medical Decision Making. The PSA decision: what YOU need to know. Developed by the Foundation for Informed Medical Decision Making and Distributed by Health Dialog, Inc. Available online at: www.healthdialog.com.

        • O’Dell K.J.
        • Volk R.J.
        • Cass A.R.
        • Spann S.J.
        Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?.
        J Fam Pract. 1999; 48: 682-688
        • Radosevich D.M.
        • Partin M.R.
        • Nugent S.
        • et al.
        Measuring patient knowledge of the risks and benefits of prostate cancer screening.
        Patient Educ Couns. 2004; 54: 143-152
        • O’Connor A.M.
        Validation of a decisional conflict scale.
        Med Decis Making. 1995; 15: 25-30
        • Degner L.F.
        • Sloan J.A.
        • Venkatesh P.
        The control preferences scale.
        Can J Nurs Res. 1997; 29: 21-43
        • Holmes-Rovner M.
        • Kroll J.
        • Schmitt N.
        • et al.
        Patient satisfaction with health care decisions: the satisfaction with decision scale.
        Med Decis Making. 1996; 16: 58-64
        • Ferrans C.E.
        • Powers M.J.
        • Kasch C.R.
        Satisfaction with health care of hemodialysis patients.
        Res Nurs Health. 1987; 10: 367-374
        • Spielberger C.D.
        State–Trait Anxiety Inventory for Adults Form Y: Review Set Manual, Test, Scoring Key.
        Mind Garden, Inc, Redwood City CA1983
        • Purvis Cooper C.
        • Merritt T.L.
        • Ross L.E.
        • John L.V.
        • Jorgensen C.M.
        To screen or not to screen, when clinical guidelines disagree: primary care physicians’ use of the PSA test.
        Prev Med. 2004; 38: 182-191
        • Paasche-Orlow M.K.
        • Parker R.M.
        • Gazmararian J.A.
        • Nielsen-Bohlman L.T.
        • Rudd R.R.
        The prevalence of limited health literacy.
        J Gen Intern Med. 2005; 20: 175-184
        • Pignone M.
        • DeWalt D.A.
        • Sheridan S.
        • Berkman N.
        • Lohr K.N.
        Interventions to improve health outcomes for patients with low literacy.
        J Gen Intern Med. 2005; 20: 185-192
        • Schwartz L.M.
        • Woloshin S.
        • Fowler Jr., F.J.
        • Welch H.G.
        Enthusiasm for cancer screening in the United States.
        JAMA. 2004; 291: 71-78
        • Ransohoff D.F.
        • McNaughton Collins M.
        • Fowler F.J.
        Why is prostate cancer screening so common when the evidence is so uncertain?.
        Am J Med. 2002; 113: 663-667
        • Whitney S.N.
        A new model of medical decisions: exploring the limits of shared decision making.
        Med Decis Making. 2003; 23: 275-280